Neuraxpharm Competitors and Similar CompaniesClear all
Neuraxpharm's competitors and similar companies include Supernus Pharmaceuticals, APEIRON Biologics, EMS Pharma and Alembic Pharmaceuticals.
 Neuraxpharm Neuraxpharm Holdco Iberia is a pharmaceutical company focusing on the treatment of central nervous system (CNS) disorders. |  Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. |  APEIRON Biologics APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies. |  EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals. |  Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates | |
Founding Date | Founding Date 2016 | Founding Date 2005 | Founding Date 2005 | Founding Date 1964 | Founding Date 2010 |
Type | Type Subsidiary | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Sant Joan Despí, ES HQ Gießhübl, AT Hradec Králové, CZ Paris, FR Langenfeld (Rheinland), DE Budapest, HU Dublin, IE see more | Locations Rockville, US HQ | Locations Wien, AT HQ | Locations BR HQ | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN |
Employees | Employees 8391% increase | Employees 6527% increase | Employees 5 | Employees 12,7441% increase | Employees 14,858 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $719m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₹73.4b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods $74.6m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹19.8b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit $644.4m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit ₹54.1b (FY, 2026) |
Net income | Net income N/A | Net income ($38.6m) (FY, 2025) | Net income N/A | Net income N/A | Net income ₹6.7b (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
Supernus Pharmaceuticals
HQ
Rockville, US
Employees
652↑ 7% increase
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View companyAPEIRON Biologics
HQ
Wien, AT
Employees
5
APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies.
View companyEMS Pharma
HQ
BR
Employees
12,744↑ 1% increase
EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
View companyAlembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View company